Nachrichten zur Boston Scientific Corp. Aktie

Image source: The Motley Fool.DateTuesday, Feb. 10, 2026 at 5 p.m. ETCall participantsChief Executive Officer — Bernard ZovighianChief Financial Officer…

Few analysts foresaw the disappointing results and profit forecast that sent Boston Scientific Corp.’s shares plummeting nearly 20% this week.…

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

Ill be keeping a close eye on Boston Scientific stock following the markets peculiar reaction to its solid earnings report.…

Image source: The Motley Fool.DATEWednesday, February 4, 2026, 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Michael F. MahoneyExecutive…

Boston Scientific Corp forecast modest 2026 revenue growth and profit just below Wall Street expectations on Wednesday, overshadowing a strong…

Image source: The Motley Fool.DateThursday, January 29, 2026 at 4:30 p.m. ETCall participantsChair and Chief Executive Officer — Kevin A.…

In the closing of the recent trading day, Boston Scientific (BSX) stood at $92.51, denoting a +1.34% move from the…

Boston Scientific ratings affirmed by Fitch, outlook positive…

New York (www.aktiencheck.de) - Boston Scientific-Aktienanalyse von Oppenheimer:Die Analysten von Oppenheimer haben das Kursziel für die Aktie von Boston Scientific…

…

Bad Marienberg (www.aktiencheck.de) - Boston Scientific-Aktie nach Milliardenübernahme unter Druck – Was Anleger jetzt wissen müssen ????Am Dienstagabend war es…

Wien (www.aktiencheck.de) - Aktien aus der Halbleiterbranche wurden gestern von TSMC (+3%) beflügelt, so die Analysten der Raiffeisen Bank International…

…

Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion.…

Boston Scientific Corp (NYSE:BSX, XETRA:BSX) announced a definitive agreement to acquire medical device company Penumbra (NYSE:PEN) in a cash and stock...…

Boston Scientific (BSX) reached $95.72 at the closing of the latest trading day, reflecting a -1.97% change compared to its…

The latest trading day saw Boston Scientific (BSX) settling at $97.79, representing a +2.42% change from its previous close.…

BSXs $50B cardiovascular business aims to outpace market growth across EP, WATCHMAN, ICTx and more.…

Boston Scientific edges out Resmed as WATCHMAN momentum, EP gains and acquisitions fuel stronger recent price performance in a growing…

…

Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the…

Boston Scientific (BSX) reached $94.48 at the closing of the latest trading day, reflecting a +1.65% change compared to its…

Toronto (www.aktiencheck.de) - Boston Scientific-Aktienanalyse von RBC Capital Markets:Die Analysten von RBC Capital haben das Kursziel für Boston Scientific Corporation…

The latest trading day saw Boston Scientific (BSX) settling at $91.75, representing a -1.02% change from its previous close.…

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.…

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

Boston Scientific (BSX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

The consensus price target hints at a 25.3% upside potential for Boston Scientific (BSX). While empirical research shows that this…

Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?…

Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.…

Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this…